Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Footnotes
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Corrigendum Free access | 10.1172/JCI81746

A human immunodeficiency caused by mutations in the PIK3R1 gene

Marie-Céline Deau, Lucie Heurtier, Pierre Frange, Felipe Suarez, Christine Bole-Feysot, Patrick Nitschke, Marina Cavazzana, Capucine Picard, Anne Durandy, Alain Fischer, and Sven Kracker

Find articles by Deau, M. in: PubMed | Google Scholar

Find articles by Heurtier, L. in: PubMed | Google Scholar

Find articles by Frange, P. in: PubMed | Google Scholar

Find articles by Suarez, F. in: PubMed | Google Scholar

Find articles by Bole-Feysot, C. in: PubMed | Google Scholar

Find articles by Nitschke, P. in: PubMed | Google Scholar

Find articles by Cavazzana, M. in: PubMed | Google Scholar

Find articles by Picard, C. in: PubMed | Google Scholar

Find articles by Durandy, A. in: PubMed | Google Scholar

Find articles by Fischer, A. in: PubMed | Google Scholar

Find articles by Kracker, S. in: PubMed | Google Scholar

Published April 1, 2015 - More info

Published in Volume 125, Issue 4 on April 1, 2015
J Clin Invest. 2015;125(4):1764–1765. https://doi.org/10.1172/JCI81746.
Copyright © 2015, American Society for Clinical Investigation
Published April 1, 2015 - Version history
View PDF

Related article:

A human immunodeficiency caused by mutations in the PIK3R1 gene
Marie-Céline Deau, … , Alain Fischer, Sven Kracker
Marie-Céline Deau, … , Alain Fischer, Sven Kracker
Brief Report

A human immunodeficiency caused by mutations in the PIK3R1 gene

  • Text
  • PDF
Abstract

Recently, patient mutations that activate PI3K signaling have been linked to a primary antibody deficiency. Here, we used whole-exome sequencing and characterized the molecular defects in 4 patients from 3 unrelated families diagnosed with hypogammaglobulinemia and recurrent infections. We identified 2 different heterozygous splice site mutations that affect the same splice site in PIK3R1, which encodes the p85α subunit of PI3K. The resulting deletion of exon 10 produced a shortened p85α protein that lacks part of the PI3K p110-binding domain. The hypothetical loss of p85α-mediated inhibition of p110 activity was supported by elevated phosphorylation of the known downstream signaling kinase AKT in patient T cell blasts. Analysis of patient blood revealed that naive T and memory B cell counts were low, and T cell blasts displayed enhanced activation-induced cell death, which was corrected by addition of the PI3Kδ inhibitor IC87114. Furthermore, B lymphocytes proliferated weakly in response to activation via the B cell receptor and TLR9, indicating a B cell defect. The phenotype exhibited by patients carrying the PIK3R1 splice site mutation is similar to that of patients carrying gain-of-function mutations in PIK3CD. Our results suggest that PI3K activity is tightly regulated in T and B lymphocytes and that various defects in the PI3K-triggered pathway can cause primary immunodeficiencies.

Authors

Marie-Céline Deau, Lucie Heurtier, Pierre Frange, Felipe Suarez, Christine Bole-Feysot, Patrick Nitschke, Marina Cavazzana, Capucine Picard, Anne Durandy, Alain Fischer, Sven Kracker

×

Original citation: J Clin Invest. 2014;124(9):3923–3928. doi:10.1172/JCI75746.

Citation for this corrigendum: J Clin Invest. 2015;125(4):1764–1765. doi:10.1172/JCI81746.

The authors recently identified an error in the identification numbers assigned to patient samples that resulted in an incorrect clinical and immunological description of patient 4 (P4). The error did not affect the conclusions of the manuscript; however, the correct immunological profile is now included in the revised version of Table 1, which appears below.

Table 1

Clinical and immunologic features

Corrected text for the clinical description is provided below:

Results and Discussion, 1st paragraph:

All 4 patients had been suffering from recurrent respiratory bacterial tract infections from soon after birth, although none of them was hospitalized to treat infections (Table 1 and Supplemental Figure 1; supplemental material available online with this article; doi:10.1172/JCI75746DS1). They had no signs of allergy, autoimmunity, splenomegaly, or lymphadenopathy (with the exception of patient 1 [P1], whose tonsils had been removed in 2 separate operations). Although viral infections and opportunistic bacterial or fungal infections were not reported, P2 and P4, but not P1, presented with EBV viremia, as detected by PCR (P2, 1,500 copies per ml; P4, 540 copies per ml; reference values, <182, respectively). P2 also presented with CMV viremia (CMV, 9,300 copies per ml; reference values, <446). Lymphocyte counts were in the normal range, but the frequency of CD31+CD45RA+ naive CD4 and CCR7+CD45RA+ naive CD8 peripheral blood T cells was low in all patients (Table 1). An elevated proportion of CD8 T cells expressing the senescence–associated marker CD57 was observed in the 3 infant patients (P1, P2, and P4). P1 displayed a memory B cell deficiency. All patients had elevated frequency of transitional B cells (Table 1). Impaired B cell function was suggested by the serum Ig profile: undetectable IgA levels in all patients; very low IgG levels in P1 and P2 (but elevated levels in P3); and elevated IgM levels in all 4 patients. All the patients but P3 were receiving Ig replacement therapy. The immunological phenotype of these patients was somewhat heterogeneous and reminiscent of that observed in APDS. The presence of dominant gain–of–function mutations of PIK3CD was ruled out for all 4 patients (data not shown). P2 presented with growth retardation (–2 SD for weight and –2.5 SD for height), without improvement after treatment with Ig replacement therapy. P4 also presented with slight growth retardation (–1.5 SD for weight and –2 SD for height).

The authors regret the errors.

Footnotes

See the related article beginning on page 3923.

Version history
  • Version 1 (April 1, 2015): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Footnotes
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts